1. Home
  2. BLTE vs TEO Comparison

BLTE vs TEO Comparison

Compare BLTE & TEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$129.67

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Logo Telecom Argentina SA

TEO

Telecom Argentina SA

N/A

Current Price

$9.60

Market Cap

5.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
BLTE
TEO
Founded
2018
1979
Country
United States
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.4B
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
BLTE
TEO
Price
$129.67
$9.60
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
★ $233.00
$16.87
AVG Volume (30 Days)
142.0K
★ 330.8K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
★ 2.66%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.44
Revenue Next Year
N/A
$2.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$115.41
$9.75
52 Week High
$200.00
$16.34

Technical Indicators

Market Signals
Indicator
BLTE
TEO
Relative Strength Index (RSI) 32.18 30.02
Support Level N/A N/A
Resistance Level $158.76 $12.46
Average True Range (ATR) 9.11 0.46
MACD -1.46 0.01
Stochastic Oscillator 19.04 4.48

Price Performance

Historical Comparison
BLTE
TEO

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About TEO Telecom Argentina SA

Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company operates in segments: ICT Services provided in Argentina: Personal Network; ICT Services provided in Argentina - TMA Network; and Other segments..

Share on Social Networks: